Cadila Pharmaceuticals.1

Prepared By: Sahil Shah

B.K.School Of Business Management,

Ahmedabad.

04/08/2023 By:Sahil Shah 1

Cadila Pharmaceuticals

CONTENTS

Vision and Mission History Partitions of the company Current scenario Segments of the company R & D Manufacturing plants Production capacity Thoughts of founder Contact details Reference


“Company’s vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment."


Vision

To discover, develop and successfully market pharmaceutical products to prevent, diagnose, alleviate and cure diseases.

To provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development.


Mission

HistoryCadila Laboratories was founded by Shri. Ramanbhai Patel and Shri. Indravadanbhai Modi in 1952.

The company evolved over the next four decades into one of India's established pharmaceutical companies.

Soon it became one of the largest pharmaceutical companies of India.


In 1995,


Cadila Laboratories

Zydus Cadila Cadila Pharmaceuticals

Partitions of company

Zydus Cadila is now being run by Mr.Pankaj Patel, son of Mr.Ramanbhai Patel.

Cadila Pharmaceuticals is now being run by Dr.Rajiv Modi, son of Mr.Indravadanbhai Modi.


Partitions of company

Cadila Pharmaceuticals Ltd. is one of the largest privately held pharmaceutical companies in India, headquartered at Ahmedabad, in the state of Gujarat.Over the last five decades, it has been developing and manufacturing pharmaceutical products and selling and distributing these in over 50 countries around the world.Cadila Pharmaceuticals is the first Indian company to get IND approval by USFDA for clinical trials to be conducted in India.Its last year’s turn over was more than Rs.500 crore.


Current scenario


Different segments of the company

• Cadiovascular• GIT (Gastro Intestinal)• Analgesics• Haematinics• Anti-infectives• Anti-biotics• Respiratory agents• Anti-diabetics• Immunologicals

One of India's most reputed, Research based, tech-savvy pharmaceutical companies focusing on areas - Formulations both Human and Veterinary, Active Pharmaceutical Ingredients, New Drug Discovery, Novel Drug Delivery, Analytical Research, Phytochemistry, Biotechnology, Plant Tissue Culture, Biosynthesis, Genetic Engineering, Vaccines, Immunoglobulins - the entire gamut of a True Life Sciences Company.

“RISORINE”-an anti T.B. drug was very much important molecule invented by the company.


R & D

R & D centre is Spreaded over more than 1,05,000 sq. ft. area with latest R & D facilities, recognized by the Department of Science & Technology, Government of India, are manned by a 150-strong scientists’ pool.

A centralized Quality Control & Analytical Research Laboratory has been set up to meet the domestic and international quality standards.

One of the few companies in the country carrying out collaborative research, Cadila Pharmaceuticals taps the best scientific talent in the country and has collaborations with more than 30 leading Research and Development centers in India.


R & D

World's first Sparfloxacin Eye Drops (Scat Eye Drops) World's first parenteral formulation of Rabeprazole (Rabeloc) World's first Probiotic combined with anti-infective agent World's first manufacturer of a unique immunomodulator World's first whole blood, rapid HIV detection kit (NEVA HIV)


World’s First By Cadila Pharmaceuticals

Cadila Pharmaceuticals has a multicultural, multilingual and multinational workforce of more than four thousand employees including over two hundred people outside India in forty-nine countries of Africa, CIS, Japan and USA.

Future plans of this company is to expand this company to each and every corner of the world.


Men force

Manufacturing plants: Kadi,

Dholka,

Daskroi,

Buddy (Haryana),

Jammu.


• Tablets: 4,320 million• Dry Syrup:12 million bottles • Dry powder vials:24 million• Liquid (oral):6,000 Kilo litres• Granules:15.6 million sachets

• Capsules:750 million• Vials: 90 million• Ampoules:84 million• Eye drops: 5 million bottles• Ear drops: 4.6 million bottles


Global Scale Production Capacities


Closing Thoughts(According to Shri. Modi)

“We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered that, the larger they have been.” -- Shri. Indravadanbhai Modi.

Indian Pharmaceutical Industry has the potential to…

1. Bring Affordability and Accessibility of Drugs to the Masses

2. Increase Global Pharma Industry’s Innovation Capacity to Meet Unmet Needs

3. But needs to get the basics right

HR Contact- Renu Ratra,

HR Manager,

Cadila Pharmaceuticals.

e-mail: [email protected]


Corporate & Registered OfficeCADILA CORPORATE CAMPUSSarkhej-Dholka Road,Bhat, Ahmedabad-382 210, INDIA.Phone : +91-2718-225001 (15 Lines)Fax :+91-2718-225039e-mail : [email protected]

Contact details

www.wikipedia.comwww.google.comwww.cadilapharma.com


References:

Cadila Pharmaceuticals.1

Documents

Transcript of Cadila Pharmaceuticals.1